Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)

NCT02026609 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02026609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02026609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Lead sponsor
University of Arkansas
Phase
Observational
Overall status
Terminated
Start date
May 31, 2013
Completion date
January 27, 2015
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatic encephalopathy, hepatic hydrothorax, refractory ascites